Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
394K
-
Shares change
-
+106K
-
Total reported value, excl. options
-
$3.92M
-
Value change
-
+$1.05M
-
Number of buys
-
8
-
Price
-
$9.96
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q4 2014
9 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q4 2014.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 394K shares
of 65.9M outstanding shares and own 0.6% of the company stock.
Largest 9 shareholders include Krasney Financial LLC (288K shares), AMERICAN INTERNATIONAL GROUP INC (47.5K shares), GLENMEDE TRUST CO NA (27.6K shares), NEW ENGLAND SECURITIES CORP /MA/ (16.2K shares), HARDESTY CAPITAL MANAGEMENT CORP (12K shares), BANK OF AMERICA CORP /DE/ (800 shares), Hoxton Financial, Inc. (800 shares), ROYAL BANK OF CANADA (800 shares), and PNC Financial Services Group, Inc. (100 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.